Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Metastatic Melanoma. Show all posts
Showing posts with label Metastatic Melanoma. Show all posts
Monday, June 10, 2013

FDA Approves Tafinlar (dabrafenib) for Advanced Melanoma

›
In conyinaution of my update on Dabrafenib   GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA...
Saturday, September 8, 2012

Provectus Pharmaceuticals - ASCO 2010

›
 We know that, Rose Bengal (4,5,6,7-tetrachloro-2',4',5',7'-tetraiodofluorescein) is a stain. Its sodium salt is common...
Sunday, January 30, 2011

Iniparib Phase III study in metastatic triple-negative breast cancer does not meet primary goal

›
A randomized Phase III trial evaluating iniparib (BSI-201) in patients with metastatic triple-negative breast cancer (mTNBC) did not ...
Monday, August 30, 2010

Experimental drug PLX4032 holds promise against cancers with faulty BRAF gene....

›
Plexxikon  recently announced the publication of data from the Phase 1 clinical trial of PLX4032 (RG7204), confirming that treatmen...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.